CTIP Accelerator Announces 2022 Finalists for Catalyzing Pediatric Innovation Annual Grant Competition

LOS ANGELES, CALIFORNIA - JUNE 13, 2022 - Now in its sixth year, the CTIP Catalyzing Pediatric Innovation Grant remains competitive. CTIP received numerous Letters of Intent for our 2022 Catalyzing Pediatric Innovation Grant and is excited to share the many innovative products and concepts submitted for application in the pediatric medical device space. 

By the numbers: Applications from 24 states, including 35% of applications from California

All device classes:

  • 26% Class I
  • 51% Class II
  • 8% Class III
  • 14% TBD

22 different Pediatric Subspecialties

  • Most common: Neonatology & Cardiovascular

CTIP is committed to diversity, equity, and inclusion. We believe in supporting individuals from diverse and historically underrepresented backgrounds in the fields of science, technology, engineering, and business. By application, members of the company’s founding or executive team (for example: CEO, COO, CFO) identify as:

  • 38.3% Woman
  • 18.3% Person of Color
  • 15.8% Underrepresented minority in STEM
  • 5.83% LGBTQ+ individual
  • 2.50% Person with Disability(ies)
  • 0.83% Veteran
  • 12.5% None apply
  • 5.83% Prefer not to disclose

The 2022 finalists, announced June 13, 2022 are as follows:

Seattle Children's Research Institute, University of Washington

"Joint thermometer", a software decoding infrared thermal images from patients with arthritis provides hope for accurate and convenient monitoring of joint health with increasing usage of telehealth.   

Facebook: @seattlechildrens Instagram: @seattlechildrens LinkedIn: Seattle Children’s Twitter: @seattlechildren

Nanodropper, Inc.

The Nanodropper is an eyedrop bottle adaptor that creates smaller eyedrops, or microdrops, which have been shown to minimize the incidence and severity of side effects relative to standard drops. 

Facebook: @nanodropper Instagram: @nanodropper LinkedIn: Nanodropper, Inc. Twitter: @nanodropper


Smileyscope™ is a leading pioneer in virtual and augmented reality (VR/AR) therapeutics focused on managing pain, anxiety, and mental health for patients. 

Facebook: @Smileyscope LinkedIn: @Smileyscope Twitter: @smileyscope

Linear Health Sciences

The Orchid SRV™ connects via standard luer-locking connection, allowing flow during IV therapy. The Orchid SRV™ is designed to allow the device to separate into two halves when excessive tension acts on the Orchid SRV™, automatically closing the flow path to both IV extension set and IV administration set. Following separation, a component of the Orchid SRV™ is left attached to each side of the infusion system to protect the intraluminal pathway. Upon separation, replacement of the SRV™ is necessary. Follow institutional policy to replace the SRV™, or at least every seven (7) days.

LinkedIn: Linear Health Sciences Twitter: @LinearSciences

Luminoah, Inc

The enLumin is a portable, intuitive, and connected enteral feeding system designed to transform the lives of those who require supplemental nutrition. 

LinkedIn: Luminoah

Eclipse Regenesis, Inc.

The Eclipse XL1 Distraction Enterogenesis System utilizes a mechanical device to stimulate the body to grow new intestines as a treatment for short bowel syndrome.

Facebook: Eclipse Regenesis Instagram: @eclipseregenesis LinkedIn: Eclipse Regenesis Twitter: @EclipseRegen

ObvioHealth Research

AudioScribe AI assists clinicians in tracking audible noise patterns for pre- and non-verbal patients who cannot communicate pain or other symptoms—such as coughs, cries, fussing, and vegetative noises.

LinkedIn: ObvioHealth

University of Pennsylvania Schools of Medicine and Engineering

Our multidisciplinary team is building a novel implantable muscle replacement that harnesses intrinsic peripheral signals in order to restore facial movement for patients with peripheral nerve and muscle disorders.

Facebook: @pennmed, Penn Engineering Instagram: @pennmedicine, @pennengineering LinkedIn: Penn Medicine, University of Pennsylvania Health System, Penn Engineering Twitter: @PennMedicine, @PennEngineers

Dell Medical School at the University of Austin

A Next Generation Solution for Optimizing Monitoring and Ventilatory Support in the Sick Newborn.

Facebook: Dell Medical School - UT Austin Instagram: @dellmedschool LinkedIn: Dell Medical School at the University of Texas at Austin Twitter: @DellMedSchool

Omaroon Corporation

Omaroon is addressing an unmet need of phenylketonuria (PKU) treatment by enabling patients with PKU to rapidly monitor their blood phenylalanine levels.

Facebook: Omaroon Corporation Twitter: @realOmaroon

Equalize Health

Equalize Health is launching a neonatal CPAP, FlowLite, with features designed to solve the key barriers to delivering effective therapy for newborn respiratory distress in low-resource settings.  

Facebook: @EqualizeHealth LinkedIn: Equalize Health Twitter: @EqualizeHealth

For more updates from CTIP about pediatric MedTech follow us @westcoastctip on Twitter, Facebook & Instagram, Consortium for Technology & Innovation in Pediatrics on LinkedIn and the web at www.westcoastctip.org

The West Coast Consortium for Technology & Innovation in Pediatrics (CTIP) is an FDA-funded pediatric MedTech accelerator centered at Children's Hospital Los Angeles. Our goal is to facilitate the development, production, and distribution of pediatric medical devices by identifying companies working in the space and providing advice, networking, and direct and indirect financial support on the road to commercialization.

Contact us at info@westcoastctip.org